In the provisions of the next important global pandemic, it is essential that the global response to the COVID-19 pandemic is evaluated. Special now, as we see more emerging diseases in unexpected areas and guests in response to changing climate patterns and other important factors such as globalization, we must be prepared for rapid and profitable potential. To do so, a greater weight in the manufacture and distribution of vaccines must be placed, both in the United States and around the world, since we saw important imbalances in the world’s response to COVID-19 that highlighted the gaps in accessibility.
Looking back in our response to COVID-19 in this milestone during the year and five years since the beginning of the pandemic in 2020, we must use as a turning point to understand the frequency factors of the pandemics and reinforce the importance of the importance of the tesforce that the force of force that has no access.
The shortening pandemic cycle
An analysis of new outbreaks of diseases of infectious diseases such as cholera, influenza and typhoid in the last 400 years in the minutes of the National Academy of Sciences suggests that statistically, extreme events like 19 are not rare of 19. The authors found that the probability of a pandemic with a similar impact to COVID-19 was approximately 2% in any year, which means that an individual has approximately 38% of possibilities of experiencing a pandemic like COVID-19 in your life.
However, this is just a statistic. There is no timeline or edges, when it comes to diseases. As a society, we must remember that the world could experience another important global pandemic at any time, especially taking into account the following factors that contribute to a faster pandemic cycle:
- Agricultural interactions and human animals Worldwide, there is a demand with animal products, with a reduction in extreme poverty that plays an important role in this demand along with other factors, such as urbanization. With more monetary resources, people tend to have more diets that include greater consumption of dairy and meat, unlike cereals, roots and tubers. As the demand for animals based on animals increases, more people are closer to animals, which leads to the transmission of diseases sounded to humans. A recent example of this in the United States is aviar flu (Aviar influenza). With avian flu, human infections can occur when the virus enters the eyes, nose or mouth of a person, or are inhaled. Dairy producers and workers can infect when, for example, raw milk splash in their eyes, nose or mouth, or when they touch these areas after handling or touching a contaminated surface.
- Climate change – Global warming not only impacts the temperatures of our planet or sea level. It also affects the way viruses spread between species. For example, consider changes in habitat, since the habitats of wild animals are lost due to climate change, they venture closer to humans. This variation in animal behavior indicates a greater risk of animal diseases that spill to humans and new developing pathogens. The shortest and most warmer winters and the longest summers are also linked to more diseases transmitted by vectors such as Lyme, malaria and influenza disease, for which the temperature variature can increase the risk of epidemics. In addition, the increase in coastal water temperatures can affect the propagation of water transmitted diseases, and fungal pathogens are also changing location, such as valley fever, a fungal infection with a case that moves north in the United States.
- Globalization – The world is becoming more globalized, which means that it is a growing interdependence of the world’s economies, cultures and populations. This is produced by the cross -border trade of goods and services, technology and investment flows, people and information. When considering thesis flows, it is essential to remember that infectious diseases do not know borders. The globalization and geography of economic relations were recognized as the main drivers of spatial structuring and the speed of the international propagation of COVID-19.
- Antigenic – An antigenic change occurs when viruses exchange entire sections of their genomics, which leads to changes in antigen genes, which can lead to completely new virus strains. Pandemics are almost always the result of antigenic change events, since virus strains with new lines have a very poor immunity among populations. Taking into account globalization and other factors, antigenic changes only exacerbate virus spread, as a combination of low population immunity and global interconnection in these days and age it is easier for infectious diseases to spread.
As a society, it is essential for us to be aware of how thesis factors are promoting risk with pandemics. Taking into account the thesis risks, we must ensure that we are prepared to respond to the next worldwide pandemic, which requires having the ability to respond.
The role of biomanocation capacity in the next pandemic
The response to COVID-19 presented significant gaps in the preparation of the pandemic and revealed opportunities to improve infrastructure, manufacturing and distribution of the global vaccine. Duration Covid-19 pandemic, most of the world’s least vaccinated countries were low and medium-sized countries (LIMCS). If countries are not doing or importing enough vaccines to meet their demand, then access becomes a critical problem. Factors that include dose hoarding by high-income countries, export restrictions, manufacturer delays, slow deployment in the country and dose donations with shelves left significant portions of Limcs vulnerable populations vulnerable to COVID-19.
To ensure that everyone has equitable access to vaccines, bioman -abuse capacity must be distributed everywhere, and these countries must make vaccines themselves. The ability to produce biological products at a faster rate, with a more consistent quality and lower costs, will be essential to meet future global health needs, especially taking into account the growing pressure to address emerging diseases and a population that ages.
Manufacturing (CM) continues, a manufacturing process that sends materials directly and immediately to the next step of the process, is to rationalize and optimize bioprocessing operations and allows it to be an expert to administer processes and a larger Eaeater Eraater was Greateryyyyyyy. This distributable manufacturing approach of lower cost democratizes biomanocation technology and expands access to treatments that save life by empowering smaller players to produce biological products such as vaccines without the need for a large initial capital investment. In some cases, CM allows the localized production of biological products, reducing the dependence of global supply chains and increasing the reliability of the availability of essential medicines in remote areas. As technology progresses, high quality biological products will be more affordable, accessible and faster to produce, ultimately revolutionizing the provision of global medical care.
Given the increasingly fast pandemic cycles, technological approaches such as CM have the potential to address critical challenges in global health and allow us to move towards a future where all countries have equitable access to vaccines. Beyond this, prosperous bioecomies and general medical or biotechnology sovereignty in Limcs will not only strengthen the capacity of the thesis countries to respond to the next global pandemic and global regional epidemics, but also health health. In general. General Pave Pave Pave Pave Pave Pave Pave Pave. Looking back in our response to the Covid-19 pandemic, it is essential that we evaluate our approach and actions to ensure that our populations are well prepared for the next important event.
Photo credit: Geber86, Getty Images
Dr. Kerry Love is the co -founder and CEO of Sunflower Therapeutics, a biotechnology company directed by women and aimed at the manufacturing solutions of upcoming generos that anyone can use to create new medications, food and other innovatives. Kerry is an organic chemist training, conducting his doctoral studies at MIT, and a biotechnology entrepreneur in the heart, since he founded two companies and contributed to the beginning of many more in the last twenty years.
This publication appears through Medical influencers program. Anyone can publish their perspective on business and innovation in medical care in Medcity News through influential people of Medcy. Click here to find out how.